Skip to main content
OpenTrials
Completed

NCT Number: NCT05915338

Training on Using ıInsulin in Patients With Type 2 Diabetes

This study was conducted to evaluate the effect of individual insulin use training given to patients with type 2 diabetes using insulin on safe drug administration, pain level and perception of treatment. The study was conducted between October 2022 and March 2023 with a randomized control group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Insulin Dependent Diabetes Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Diabetes type2 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Şirnak Devlet Hastanesi

Şirnak, Merkez, 73000, Turkey (Türkiye)

About this study

Objective: The aim of this study was to examine the effects of individual insulin use training given to patients with Type 2 diabetes on safe drug administration, pain level and treatment perception, and to contribute to both national and international literature.

Method: It was conducted between October 2022 and March 2023 as a randomized controlled study in a pre-test-post-test order to determine the effect of individual insulin use education given to patients with type 2 diabetes on safe drug administration, pain level and treatment perception. The data were collected by the researchers with the descriptive information form of the patients, the Insulin Administration Skill Observation Form, the Visual Analogue Scale and the Insulin Therapy Evaluation Scale.

Data Collection: Face-to-face and individual interviews with patients who applied to the Internal Diseases and Endocrinology Polyclinic and Diabetes Nursing Polyclinics of a state hospital in a city located in the Southeastern Anatolia Region of Turkey, and who were hospitalized in the Internal Diseases, Endocrinology, Physical Therapy and Rehabilitation and Cardiology Services. collected using the method. A pilot study was not conducted before starting the study. Before the study, all patients were informed about the study and their verbal and written consents were obtained.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients included in the study;

  • 18 years and over Using insulin injections for at least six months or longer
  • Meeting the American Diabetes Association (ADA, 2021) diagnostic criteria for Type 2 diabetes
  • No communication and mental problems
  • Insulin injection made by himself or his family The patients who agreed to participate in the study.

Exclusion criteria

Patients excluded from the study;

  • Self or family member health personnel Those with advanced retinopathy, nephropathy, neuropathy
  • Diagnosed with type 1 diabetes
  • Pregnant or breastfeeding women
  • Patients who participated in another clinical trial concurrently or within 1 month prior to the start of the trial.

Treatment and study plan

Primary outcomes

  1. Fırst follow - up survey

    Time frame: Fırst test-fırst applıcatıon both groups at the begınnıng of the research

    Pretest data was obtained using the introductory information form, IASOF, VAS, and ITES.

    Patients were requested to apply their daily dose of insulin to themselves and patients' application skills were recorded by the researchers into IASOF as the 1st observation.

Secondary outcomes

  1. Last test survey

    Time frame: 2 weeks after the fırst watch

    Posttest data was obtained through the use of IASOF, VAS, and ITES. Patients were requested to apply their insulin dose of the day to themselves. Patients' insulin application skills were recorded by researchers into IASOF as the 2nd observation.

Other outcomes

  1. Durabılıty test for both groups

    Time frame: After 8 weeks, the follow-up test was done to both groups

    Posttest data was obtained through the use of IASOF, VAS, and ITES. Patients were requested to apply their insulin dose of the day to themselves. Patients' insulin application skills were recorded by researchers into IASOF as the 3rd observation.

Sponsors and collaborators

Lead sponsor

Inonu University

Other

Registry information

Official study title

The Eof ıInsulin Use Education on Safe Drug Administration, Pain Level and Perception of Treatment in Patients With Type 2 Diabetes

Acronym: İNSÜLİN

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jun 23, 2023
Registry last updated
Jun 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.